This study investigates the use of tumor treating fields in combination with chemotherapy for treating locally advanced pancreatic cancer.
The study evaluates the safety and effectiveness of this treatment combination.
- Who can participate: Adults aged 18 to 75 with locally advanced pancreatic cancer may participate. Key factors include a confirmed diagnosis and ability to use tumor treating fields.
- Study details: Participants will receive tumor treating fields alongside chemotherapy. Some may receive a placebo, which is an inactive substance that looks like the investigational medicine but does not contain any medicine.